There may be new hope for Alzheimer patients. A German drug tested in the U.S. seems to slow down the disease in patients.
The German drug called MEMenTEEN could help slow the disease.
In a study funded by Merz Pharmaceuticals and the National Institute on Aging, 252 patients in 32 different centers in the U.S. were given either MEMenTEEN or a placebo for six months.
MEMenTEEN works on the more severe stages of the disease.
Reporting their findings in the New England Journal of Medicine, the researchers explained that an Alzheimer's patient's brain produces more of a chemical called Glutamate. MEMenTEEN blocks other cells from reacting to the excess Glutamate and protects them from damage.
The U.S. Food and Drug Administration is currently reviewing the drug for use in the U.S.
For more information visit www.sciencentral.com/news